Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 6, 2011, Pages 634-640

  Sciarra, Alessandro ^a   Panebianco, Valeria ^a   Salciccia, Stefano ^a   Gentilucci, Alessandro ^a   Alfarone, Andrea ^a   Dimare, Luisa ^a   Lisi, Dino ^a   Catturino, Susanna ^a   Di Pierro, Giovanni ^a   Von Heland, Magnus ^a   Ciccariello, Mauro ^a   Passariello, Roberto ^a   Gentile, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

High grade prostatic intraepithelial neoplasia; Magnetic resonance; Prostate neoplasm; Spectroscopy

Indexed keywords

CHOLINE; CITRIC ACID; CREATINE; GADOBUTROL;

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HISTOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAMETER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

AGED; CHOLINE; CREATINE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 81055138345     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.07.033     Document Type: Article

References (25)

1. Bostwick D.G., Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 2004, 17:360-379.
2. Humphrey P.A. Prostatic intraepithelial neoplasia. Prostate pathology 2003, 183-217. American Society for Clinical Pathology, Chicago, IL.
3. Qian J., Wollan P., Bostwick D.G. The extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 1997, 28:143-148.
4. Sciarra A., Panebinanco V., Salciccia S., et al. Role of dynamic contrast-enhanced magnetic resonance imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol 2008, 54:589-600.
5. Kirkham A.P., Emberton M., Allen C. How good is MRI at detecting and characterizing cancer within the prostate?. Eur Urol 2006, 50:1163-1175.
6. Anastasiadis A.G., Lichy M.P., Nagele U., et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 2006, 50:738-749.
7. Rajesh A., Coakley F.V., Khrhanewicz J. 3D spectroscopic imaging in the evaluation of prostate cancer. Clin Radiol 2007, 62:921-929.
8. Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005, 78:103-111.
9. Rajesh A., Coakley F.V. MR imaging and MR spectroscopic imaging of prostate cancer. Magn Reson Imaging Clin N Am 2004, 12:557-579.
10. Casciani E., Gualdi G. Prostate cancer: Value of magnetic resonance spectroscopy 3D chemical shift imaging. Abdom Imaging 2006, 31:490-499.
11. Sciarra A., Salciccia S., Panebianco V. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: A modern approach in prostate cancer imaging. Eur Urol 2008, 54:485-488.
12. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: Correlation with histopathologic results. Radiology 1997, 203:645-652.
13. Coakley F.V., Qayyum A., Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 2003, 170(6 pt 2):S69-S75.
14. Hom J.J., Coakely F.V., Simko J.P., et al. High-Grade Prostatic Intraepithelial Neoplasia in Patients with Prostate Cancer: MR and MR Spectroscopic Imaging Features-Initial Experience. Radiology 2007, 242:483-489.
15. Testa C., Schiavina R., Lodi R., et al. Prostate cancer: Sextant localization with MR imaging, MR spectroscopy, and 11-choline PET/CT. Radiology 2007, 244:797-806.
16. Kumar R., Nayyar R., Kumar V., et al. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/mL: A follow-up study. Urology 2008, 72:859-863.
17. McNeal J.E., Bostwick D.G. Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 1986, 17:64-71.
18. Drago J.R., Mostofi F.K., Lee F. Introductory remarks and workshop summary: Workshop on prostatic intraepithelial neoplasia-significance and correlation with prostate-specific antigen and transrectal ultrasound. Urology 1989, 34(Suppl 6):2-3.
19. Bostwick D.G., Amin M.B., Dundore P., et al. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 1993, 24:298-310.
20. Wefer A.E., Hricak H., Vigneron D.B., et al. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging, and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000, 164:400-404.
21. Fütterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006, 241:449-458.
22. Schned A.R., Wheeler K.J., Hodorowski C.A., et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 1996, 20:1501-1506.
23. Montironi R., Mazzuchelli R., Lopez-Beltran A., et al. Mechanism of disease: High-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Tract Urol 2007, 4:321-332.
24. Ploussard G., Plennevaux G., Allory Y., et al. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation on initial 21-core extended biopsy scheme: Incidence and implications for patient care and surveillance. World J Urol 2009, in press.
25. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on a step-section pathologic analysis after radical prostatectomy. Radiology 2005, 234:804-814.